Goodwin Procter advised Cubist Inc. on the deal. Cubist Inc. announced its $7 million seed round. The round was led by Polychain Capital, with participation from venture...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised PointClickCare Corp. on the deal. PointClickCare Corp. announced its acquisition of Patient Pattern. The combination of PointClickCare and Patient Pattern will further the companies’...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Qatalyst Partners on the deal. Qatalyst Partners acted as financial advisor to Momentive (Nasdaq: MNTV) in a definitive agreement to be acquired by a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Qualtrics International Inc. on the deal. Qualtrics International Inc. (NASDAQ: XM) announced its definitive agreement to be acquired by Silver Lake, in partnership...
You must be a Standard 1 Year member to access this content.
Goodwin advised Cycle Pharmaceuticals on the deal. Cycle Pharmaceuticals Ltd obtained a victory in a High Court trial: Eteboxagu AB v Cycle Pharmaceuticals Ltd [2023] EWHC 462...
You must be a Standard 1 Year member to access this content.
Goodwin advised Épopée Gestion on the sale & leaseback signing of a logistics building. Territorial investment company Épopée Gestion, co-founded by Charles Cabillic and Ronan Le...
You must be a Standard 1 Year member to access this content.
Le cabinet d’avocats international Goodwin a conseillé le fonds d’investissement Capza Transition dans le cadre de son investissement. Le management de Stanwell Consulting était conseillé par...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Juniper Square on the deal. Juniper Square announced a large debt and equity financing. The investment was led by Owl Rock, a division of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised TPI Composites, Inc. on the deal. Davis Polk advised the representative of the initial purchasers and the counterparties to the capped call transactions...
You must be a Standard 1 Year member to access this content.
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
You must be a Standard 1 Year member to access this content.
Goodwin advised Shifted Energy on the deal. Shifted Energy announced its $4.3 million seed funding round, which will help the company expand its energy efficiency solutions and...
You must be a Standard 1 Year member to access this content.
Goodwin advised Cano Health, Inc. on the deal. Cano Health, Inc. (NYSE: CANO) (the “Company”) announced its previously-announced $150 million senior secured “side-car” term loan from Diameter...
You must be a Standard 1 Year member to access this content.
